Elsevier is improving the outlook on diagnostic
decision-making through its expert-based decision support solutions
for radiologists and pathologists
SANTA CLARA, California,
Nov. 16, 2017 /PRNewswire/
-- Based on its recent analysis of clinical decision support
systems (CDSS) for the pathology and radiology industry, Frost
& Sullivan recognizes Elsevier with the 2017 North America
Technology Innovation Award for its ExpertPath™ and
STATdx® industry-leading diagnostic support systems for
pathologists and radiologists. An established leader in the CDSS
market, Elsevier offers a variety of content sources integrated
with evidence-based content for the care process to help improve
patient outcomes.
Click here for the full multi-media experience of this release –
http://bit.ly/2hrc0tp
Widely regarded as the "Gold Standard" of radiology reference
solutions, STATdx serves more than 50,000 users across 100
countries and is used in 99% of Academic Hospitals in North America. Written by renowned
radiologists in each specialty, STATdx increases accuracy and
confidence in diagnosing complex imaging cases and includes over
4,000 common and complex diagnoses, 200,000 expert-selected and
annotated image examples, more than 1,300 differential diagnosis
modules, 20,000 easily sortable patient cases with cine clips for
select topics, and much more.
ExpertPath is an anatomic and clinical pathology online
decision support solution that provides timely aid to today's
pathologists in their quest to get every diagnosis right and
provide critical information back to physicians and care teams.
ExpertPath equips pathologists working under high pressure with the
expert-based information needed for: diagnosing complex or unusual
cases; examining a case in an unfamiliar specialty area; teaching
students and residents; preparing for a lecture; and taking part in
or preparing for a tumor board Content includes differential
diagnosis lists, ancillary tests, image galleries and
specimen-handling protocols.
"With the shift in healthcare to digitalization, CDSS combines
emerging Big Data and artificial intelligence technologies for
improved clinical assessments. As a leader in the CDSS market,
Elsevier knows the worth of extensive information, but the company
also understands that the information must be easily accessible to
optimize its value in diagnostic decisions," states Frost &
Sullivan's Divyaa Ravishankar, Industry Principal. "Elsevier
designed its solutions to push relevant and easily searchable data,
ensuring physicians are not overburdened with non-relevant
information."
Elsevier's platform content is available in nine
languages—Simplified Chinese, Traditional Chinese, Spanish,
Portuguese, Brazilian Portuguese, Italian, German, French, and
Japanese—facilitating access for global users.
"Elsevier's customer support is outstanding. They have expert
teams working to guarantee the reference material is the most
up-to-date available, in addition to providing a field service team
to help new customers use the platform efficiently for improved
clinical utility," said Ravishankar. "The company is ahead of the
curve regarding what customers need. While the radiology health
segment transitioned to digitalization a decade ago, the pathology
segment is just starting to embrace it, so the ExpertPath solution
comes at the right time for the right people."
Elsevier is creating innovative products, such as STATdx and
ExpertPath, providing physicians easy access to relevant
information for improved clinical assessments. For this reason,
Elsevier earns Frost & Sullivan's 2017 North America Technology
Innovation Award.
Each year, Frost & Sullivan presents this award to the
company that develops products with innovative features and
functionality that are gaining rapid acceptance in the market. The
award recognizes the quality of the solutions and the customer
value enhancements they enable.
Frost & Sullivan Best Practices awards recognize companies
in a variety of regional and global markets for demonstrating
outstanding achievement and superior performance in areas such as
leadership, technological innovation, customer service, and
strategic product development. Industry analysts compare market
participants and measure performance through in-depth interviews,
analysis, and extensive secondary research to identify best
practices in the industry.
About Elsevier
Elsevier is a global information
analytics business that helps institutions and professionals
progress science, advance healthcare and improve performance for
the benefit of humanity. Elsevier provides digital solutions and
tools in the areas of strategic research management, R&D
performance, clinical decision support, and professional education;
including ScienceDirect,
Scopus, SciVal, ClinicalKey and Sherpath.
Elsevier publishes over 2,500 digitized journals,
including The Lancet and Cell, more
than 35,000 e-book titles and many iconic reference works,
including Gray's Anatomy. Elsevier is part of RELX
Group, a global provider of information and analytics for
professionals and business customers across
industries. www.elsevier.com
About Frost & Sullivan
Frost & Sullivan, the
Growth Partnership Company, works in collaboration with clients to
leverage visionary innovation that addresses the global challenges
and related growth opportunities that will make or break today's
market participants. For more than 50 years, we have been
developing growth strategies for the global 1000, emerging
businesses, the public sector, and the investment community.
Contact us: Start the discussion.
Media Contacts:
Christopher Capot
Director, Global Communications
Elsevier
+1 917 704 5174
c.capot@elsevier.com
Andrea Steinman
Frost & Sullivan
P: 210.477.8425
F: 210.348.1003
E: Andrea.steinman@frost.com